A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
NCT00559117
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced and/or Metastatic Solid Organ Cancer
Interventions
DRUG:
VB-111
Sponsor
Vascular Biogenics Ltd. operating as VBL Therapeutics